l9n/ New Jersey

2026–2027 Session

Assembly Bill 4852

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Became P.L.2026, c.40, on July 8, 2026.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the General Assembly

2 co-sponsors

Robert J. Karabinchak, Margie Donlon M.D.

In the Senate

Its course

May 4 to July 8, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action8 actions on 4 days

In the General AssemblyMay 4 to Jun 3057 days

HealthMay 4 to Jun 23 · moved on50 days

State and Local GovernmentJun 23 to Jun 230 days

In the SenateJun 30 to Jun 300 days

With the GovernorJun 30 to Jul 88 days

Votes

Yeas to nays, as the Legislature recorded them. Committee votes are set in.

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the General Assembly May 4 – Jun 30

  1. Introduced in the General Assembly and sent to Health
  2. Sent to State and Local Government
  3. State and Local Government recommended it as amended
  4. Read a second time
  5. Passed the General Assembly, 76 to 2

In the Senate Jun 30

  1. Arrived in the Senate
  2. Read a second time
  3. Passed the Senate, 38 to 2, and so both houses

To the Governor Jul 8

  1. Signed by the Governor
  2. Became P.L.2026, c.40
All 8 actions, as published